Jackman Liam, Kamran Rakhshan
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
BMJ Open. 2025 Jan 2;15(1):e086927. doi: 10.1136/bmjopen-2024-086927.
Gender-affirming care refers to a range of social, psychological, medical and/or surgical interventions provided to affirm one's gender. Pharmacists play a key role in gender-affirming care and are involved with choosing optimal treatments, monitoring progress/side-effects and providing education. However, it is currently unknown what gender-affirming care education is provided to pharmacy students and pharmacists according to information available in published literature. This is important to identify potential education gaps in pharmacy curricula and an understanding of the current state of gender-affirming care education in pharmacy.
This scoping review protocol follows guidance from Arksey and O'Malley and Levac and colleagues. The population, concept and context framework are used to specify the research question and subsequently the search strategy. Database searching will occur across four databases: Medline, Embase, APA PsycINFO and Scopus; with the search date ranging from inception to 1 January 2025. Eligible studies will include pharmacy students or pharmacists, and examine the presence of gender-affirming care pharmacy education in Canada and the USA. There are no restrictions to date. Article screening and extraction will occur independently and in duplicate. Educational interventions, gender-affirming care content and recommendations extracted from each article will be narratively synthesised. This work is undertaken with patients and public involvement.
Ethical approval is not required as this is a review of published studies and does not collect any human data. Results will be disseminated through a peer-reviewed publication and conference presentations.
性别肯定治疗是指为确认一个人的性别而提供的一系列社会、心理、医学和/或外科干预措施。药剂师在性别肯定治疗中发挥着关键作用,参与选择最佳治疗方案、监测进展/副作用并提供教育。然而,根据已发表文献中的现有信息,目前尚不清楚为药学专业学生和药剂师提供了哪些性别肯定治疗教育。确定药学课程中潜在的教育差距以及了解药学中性别肯定治疗教育的现状非常重要。
本范围综述方案遵循阿克西和奥马利以及莱瓦克及其同事的指导。使用人群、概念和背景框架来明确研究问题,进而确定检索策略。将在四个数据库中进行检索:医学文献数据库(Medline)、荷兰医学文摘数据库(Embase)、美国心理学会心理学文摘数据库(APA PsycINFO)和Scopus;检索日期从数据库建立至2025年1月1日。符合条件的研究将包括药学专业学生或药剂师,并考察加拿大和美国性别肯定治疗药学教育的情况。对日期无限制。文章筛选和提取将独立且重复进行。从每篇文章中提取的教育干预措施、性别肯定治疗内容和建议将进行叙述性综合。这项工作是在患者和公众参与下开展的。
由于这是对已发表研究的综述,不收集任何人类数据,因此无需伦理批准。研究结果将通过同行评审出版物和会议报告进行传播。